OBJECTIVES This study introduces a newly designed transcatheter aortic valve system, the J-Valve system, and evaluates its application in patients with predominant aortic regurgitation without significant valve calcification. We also report the early results of one of the first series of transapical implantations of this device and aim to offer guidance on the technical aspects of the procedure.
which helps to determine the optimal curvature of the delivery system during the procedures ( Figure 1D ).
Two-dimensional images were also reconstructed to measure the distance between the ostia of coronary arteries and the annulus ( Figures 1E and 1F) . The details of coronary arteries were reconstructed to rule out significant coronary stenosis. The prosthesis and delivery system were assembled after the size of the prosthesis was confirmed.
The projection of left ventricle apex on the chest wall was localized under fluoroscopy to determine the optimal incision. A 5-F introducer was inserted in the demonstrated in a heart model in vitro ( Figure 4 ).
Functioning of the prosthesis was assessed by TEE immediately (Figures 2B and 2C).
After the guidewire was removed, the apical sutures were tied, and 1.5 mg/kg protamine was administered. Then hemostasis was achieved. A final aortic root angiogram was obtained to assess the prosthesis function and to confirm that both coronary ostia were patent
Step-by-Step Implantation
Step-by-step transapical implantation (Patient #6) of a 27-mm J-Valve prosthesis (JieCheng Medical Technology Co., Ltd., Suzhou, China). Wei et al.
Implantation of the J-Valve and Early Outcome Step-by-Step Implantation Demonstration In Vitro
Step-by-step implantation of the J-Valve prosthesis (JieCheng Medical Technology Co., Ltd.) in a heart model in vitro. (E, F) The 2-and 3-dimensional reconstructions showing the prosthesis in the aortic root. MSCT ¼ multislice computed tomography.
Wei et al. Table 2 . The appropriate size of the prosthesis was determined to be 5% to 10% larger than the native annulus diameter. Based on the aortic annulus diameter measured by MSCT and TEE, 3 25-mm and 3 27-mm prostheses were implanted. Hemostasis was easily achieved in all cases without significant blood loss. Table 3 . Detailed clinical outcomes and follow-up data are listed in Table 4 . The results of the latest echocardiographic follow-up are listed in Table 5 . Tables 1 and 2 . Abbreviations as in Tables 1 to 3 . wcs_heartsurgeon@126.com.
ADVANTAGES OF THE MOVABLE CONNECTION

